C5aR ligand peptide 3D QSAR study performed with an applied linear conformation.
A 3D quantitative structure-activity relationship study (QSAR) of binding and activation of the human C5a receptor by peptide analogs of the C-terminal binding domain of C5a anaphylatoxin is reported. Using published C5a analog affinity and activity data, this paper seeks to elucidate the pharmacophore for the high affinity C-terminal binding domain of the C5a peptide with the molecular modeling technique of comparative molecular field analysis (CoMFA). In order to model peptides for which there was incomplete conformational data, an arbitrary linear conformation was imposed upon the highly flexible C5a analogs. The resulting models yield a crossvalidated q2 of 0.889 and 0.787, for receptor-ligand affinity and EC50 calcium release activity, respectively, suggesting these models have good predictive ability for other test peptides.
Anderson
C Y
CY
Biomedical Engineering Program, Virginia Commonwealth University, Richmond, USA.
Kellogg
G E
GE
Freer
R J
RJ
D000595:Amino Acid Sequence; D015703:Antigens, CD / Q000737:chemistry*; D015936:Complement C5a / Q000378:metabolism*; D008024:Ligands; D008956:Models, Chemical; D008969:Molecular Sequence Data; D010455:Peptides / Q000737:chemistry* / Q000378:metabolism*; D011487:Protein Conformation; D044087:Receptor, Anaphylatoxin C5a; D011951:Receptors, Complement / Q000737:chemistry*; D013329:Structure-Activity Relationship
D015703:Antigens, CD; D008024:Ligands; D010455:Peptides; D044087:Receptor, Anaphylatoxin C5a; D011951:Receptors, Complement; D015936:Complement C5a